Bibliography for: "Zentiva NV, the Czech drugmaker being acquired by Sanofi-Aventis SA, said its board unanimously recommended that shareholders accept the French company's offer and tender their stock"

"Zentiva NV, the Czech drugmaker being acquired by Sanofi-Aventis SA, said its board unanimously recommended that shareholders accept the French company's offer and tender their stock". MondayMorning. FindArticles.com. 30 Nov, 2009. http://findarticles.com/p/articles/mi_7401/is_39_16/ai_n32058707/

MondayMorning

View more issues:

Articles in Oct 6, 2008 issue of MondayMorning

• Weekly stock performance
• Lilly reportedly in talks to buy ImClone
• Boston Scientific drops after losing J&J patent lawsuit
• Florida sues Merck for Vioxx expenditures
• One success story in an otherwise horrific week for equities was Repros Therapeutics Inc. , closing up 73 cents, or 12%, to $6.81
• Mental health coverage expanded under bailout package
• More than 90% of U.S. nursing homes in each of the past three years were cited for violating federal standards, according to a government report
• Cephalon to pay $425 million to settle federal charges
• Report says Pfizer, Sanofi could free-up $35 billion
• Advanced Life could receive $100 million from Wyeth
• Sanofi-Aventis SA. and Daiichi Sankyo Co. delayed plans to sell the first imported vaccine in Japan because it's taking longer than expected to make the product meet the country's standards
• Cardinal Health Inc. said that it's going to spin off its clinical and medical products businesses—infusion pumps, ventilators, surgical instruments, and the like
• Medtronic Inc
• Cyberonics Inc
• An analysis of dozens of studies found the widely used statin cholesterol drugs do not increase the risk of Lou Gehrig's disease, U. S. health officials said last week
• U.S. stocks slid Friday, capping the worst week for the Standard & Poor's 500 Index since the 2001 terrorist attacks, on concern the $700 billion bank bailout isn't enough to unlock credit markets and prevent a recession
• Fresenius SE, the German healthcare company buying APP Pharmaceuticals Inc. , increased the syndicated credit facilities used to pay for the acquisition by $500 million because of demand from institutional investors
• Weekly key rates
• Vitamin C supplements may undercut the effectiveness of cancer drugs including Novartis AG's Gleevec , a US study showed
• In evaluating screening mammograms for breast cancer, a single reader with computer assistance can perform just as well as two readers, the results of a new study suggest
• A variant in the gene for adiponectin—the fat tissue-secreted hormone that is inversely linked to obesity and hyperinsulinemia—is associated with decreased risk of colorectal cancer, new research shows
• Women taking hormone replacements didn't have a higher risk of heart attacks as long as they avoided daily doses of both estrogen and progesterone, according to a study of a range of treatments used by almost 700,000 women
• US health officials said on Friday they were reviewing a higher rate of deaths among patients treated with a Johnson & Johnson anemia drug in a German study of stroke patients
• The AIDS virus may have first infected humans in Africa in the late 1800s, half a century earlier than previous estimates and decades before mass migration to cities led to its emergence around the world, scientists said
• Daiichi Sankyo Co
• Zentiva NV, the Czech drugmaker being acquired by Sanofi-Aventis SA, said its board unanimously recommended that shareholders accept the French company's offer and tender their stock